Characteristics of eligible patients with knee osteoarthritis accepting versus declining participation in a randomised trial investigating the effect of weight loss versus knee arthroplasty to explore generalisability: A cross‐sectional study
Knee Surgery, Sports Traumatology, Arthroscopy · 2025
DOI: 10.1002/ksa.12546 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, 2025. Verfasst von Saber Muthanna Aljuboori und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Traumatology, Copenhagen University Hospital-Bispebjerg & Frederiksberg, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Arthroplasty, Replacement, Knee, Weight Loss, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oak Foundation, Karen Elise Jensens Fond, Novo Nordisk Foundation.
Abstract (Originalsprache)
Background
The INtensive diet versus Knee Arthroplasty (INKA) trial is a randomised trial assessing weight loss as an alternative to knee arthroplasty (KA) in obese patients with severe knee osteoarthritis (OA) awaiting KA (NCT05172843). The external validity of the INKA trial may be hampered if the patients who participate differ from those who decline participation.
Objective
To compare baseline characteristics between patients who enrol in the INKA trial and those who decline participation (i.e., non‐INKA [nINKA] group).
Methods
We applied a cross‐sectional study design, collecting and comparing baseline characteristics among all patients eligible for enrolment in the INKA trial from two clinics in Copenhagen. Imbalance between accepting (INKA) and declining (nINKA) groups was assessed using standardised differences (StdDs). We were prespecified that StdD values < 0.20 would indicate a clinically insignificant imbalance between groups, whereas values > 0.80 indicate incomparability.
Results
Of the 913 patients scheduled for KA, 888 were screened for INKA trial eligibility. Of the 217 eligible patients, 92 (42%) were enroled in the INKA trial, while 37 (17%) participated in the nINKA cross‐sectional sample only. Patients enroled in INKA had on average a less severe Oxford knee score (OKS) of 22.0 (standard deviation = 6.7) compared to declining participants in nINKA with 18.6 (7.2), corresponding to an StdD of 0.50, and an absolute difference of 3.45 (95% confidence interval = 0.64–6.26, p = 0.017). A consistent similar pattern was noted across all secondary patient‐reported outcomes applied in the INKA trial.
Conclusions
We observed discrepancies in patient‐reported outcomes, with those who declined enrolment reporting more severe symptoms. These differences, however, were below the minimally important difference between groups for OKS, which is set to 4.84 points. Level of Evidence Level II–III cross‐sectional study in a randomised control trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery and Traumatology, Copenhagen University Hospital-Bispebjerg & Frederiksberg, Copenhagen, Denmark.
- The Parker Institute, Copenhagen University Hospital-Bispebjerg & Frederiksberg, Frederiksberg, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
- Department of Orthopedic Surgery, Copenhagen University Hospital-Hvidovre & Amager, Hivdovre, Denmark.
- Department of Radiology, Copenhagen University Hospital-Bispebjerg & Frederiksberg, Copenhagen, Denmark.
Förderung
- Oak Foundation
- Karen Elise Jensens Fond
- Novo Nordisk Foundation
Zitieren
APA
Aljuboori, S. M., Christensen, R., Henriksen, M., Bliddal, H., Troelsen, A., Boesen, M., Poulsen, A. S., Nielsen, C. T., Bunyoz, K. I., & Overgaard, S. (2025). Characteristics of eligible patients with knee osteoarthritis accepting versus declining participation in a randomised trial investigating the effect of weight loss versus knee arthroplasty to explore generalisability: A cross‐sectional study. Knee Surgery, Sports Traumatology, Arthroscopy. https://doi.org/10.1002/ksa.12546
Vancouver
Aljuboori SM, Christensen R, Henriksen M, Bliddal H, Troelsen A, Boesen M, et al. Characteristics of eligible patients with knee osteoarthritis accepting versus declining participation in a randomised trial investigating the effect of weight loss versus knee arthroplasty to explore generalisability: A cross‐sectional study. Knee Surgery, Sports Traumatology, Arthroscopy. 2025. doi:10.1002/ksa.12546
BibTeX
@article{Aljuboori2025,
author = {Aljuboori, Saber Muthanna and Christensen, Robin and Henriksen, Marius and Bliddal, Henning and Troelsen, Anders and Boesen, Mikael and Poulsen, Asbjørn Seenithamby and Nielsen, Camilla Toft and Bunyoz, Kristine Ifigenia and Overgaard, Søren},
title = {Characteristics of eligible patients with knee osteoarthritis accepting versus declining participation in a randomised trial investigating the effect of weight loss versus knee arthroplasty to explore generalisability: A cross‐sectional study},
journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
year = {2025},
doi = {10.1002/ksa.12546}
}
EUVIMED